NeoGenix Biosciences
PrivateLast Round
Pre Seed
Mar 11, 2024
Total Funding Raised
$145,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeoGenix Biosciences operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Pre Seed round in March 2024.
NeoGenix Biosciences is a biotechnology company that develops AI-powered and microfluidic platforms to enhance sperm identification and selection for IVF procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoGenix Biosciences Comparables
Compare NeoGenix Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iPreg Inc. | 86% | |
| CytoSwim | 82% | |
| Koek Biotechnology Ltd. | 77% |
For institutional investors. Book with your work email.
NeoGenix Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 11, 2024 | ||||
| Accelerator | Oct 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeoGenix Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Australian Medical Angels | Accelerator |
| The George Institute for Global Health | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 39% MoM, reaching 798.
- Mar 11, 2024
$65K round led by Virtus Health
For institutional investors. Book with your work email.
NeoGenix Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeoGenix Biosciences's valuation, stock price, and market status.
Is NeoGenix Biosciences a public or private company?
NeoGenix Biosciences is a private company.
What is the current stock price of NeoGenix Biosciences?
NeoGenix Biosciences is a private company, so its shares have no public market price. Caplight tracks NeoGenix Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeoGenix Biosciences worth (valuation)?
Valuation information for NeoGenix Biosciences is not publicly available.
Can I buy NeoGenix Biosciences stock?
NeoGenix Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeoGenix Biosciences's last funding round?
NeoGenix Biosciences's most recent funding round was Pre Seed on March 11, 2024.
Who are the main investors in NeoGenix Biosciences?
Key investors in NeoGenix Biosciences include Australian Medical Angels, The George Institute for Global Health.
Will NeoGenix Biosciences IPO soon?
No public IPO plans have been announced for NeoGenix Biosciences.
How can I track NeoGenix Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in NeoGenix Biosciences's shares on secondary markets.